Viewing StudyNCT00418379



Ignite Creation Date: 2024-05-05 @ 5:15 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00418379
Status: COMPLETED
Last Update Posted: 2016-05-25
First Post: 2007-01-03

Brief Title: Phase III Study to Assess the Long Term Efficacy Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
Sponsor: Stallergenes Greer
Organization: Stallergenes Greer

Conditions & Keywords Data

Conditions:
Name
Allergy
Keywords:
Name View
Allergic rhinoconjunctivitis View
Sublingual immunotherapy View
Grass pollen tablet View